The distinction of Fellowship in SIDP (FIDP) recognizes outstanding SIDP members with significant and sustained contributions to infectious diseases and the mission of SIDP. Successful applicants demonstrate a commitment to promoting the appropriate use of antimicrobials for the prevention and management of infectious diseases through leadership and collaboration in infectious diseases practice, education, research, and advocacy. Nominees complete an application and provide supporting documentation, which are reviewed and scored by the Recognition Awards Committee. Successful applicants must demonstrate excellence in the area of Contributions to SIDP and at least two of the following categories: practice, education, or scholarship.
Please consider nominating a colleague for this distinction, which is awarded at the SIDP Business Meeting and Lecture Series in the fall. Further information regarding the nomination and application process can be found here.
Dr. Emily Heil is a Professor in the Department of Practice, Sciences, and Health-Outcomes Research at the University of Maryland School of Pharmacy. She is the pharmacy director of the Antimicrobial Stewardship Program at the University of Maryland Medical Center (UMMC) where she practices as an Infectious Diseases Clinical Pharmacy Specialist. She founded and is the Residency Program Director of the Infectious Diseases PGY-2 at UMMC. Her research focuses on ways that infectious diseases pharmacists can improve patient care through antimicrobial stewardship, de-labeling penicillin allergies, and individualized antimicrobial dosing. She’s passionate about changing the culture of antimicrobial stewardship away from the ‘antibiotic police’ connotation to a more collaborative and sustainable model, with a focus on protecting and preserving the stewardship workforce.
Dr. Heil has been an active member of SIDP since 2010. She has served as chairperson of the Political Advocacy Committee (2014, 2015, 2016), the Fundraising committee (2017), and Guidelines committee (2022). She served on the SIDP Board of Directors from 2017-2020 as Secretary/Treasurer. Dr. Heil is also involved with SIDP partner organizations, including representing SIDP on the Infectious Diseases Society of America (IDSA)’s sepsis task force. She is proud to call SIDP her professional home and is grateful for the connections she has made in the Society.
Dr. Elizabeth Hirsch (@EB_Hirsch) is a tenured Associate Professor in the Department of Experimental and Clinical Pharmacology at the University of Minnesota College of Pharmacy. She received B.S. and PharmD degrees from Creighton University. She then completed a PGY1 pharmacy practice residency and an infectious diseases pharmacotherapy fellowship. Dr. Hirsch served as faculty at Northeastern University and Beth Israel Deaconess Medical Center in Boston, Massachusetts, from 2011-2017, before moving her research program to the University of Minnesota in 2017. Her translational research program focuses on the detection and treatment of multidrug-resistant gram-negative infections, with the overall goal of improving the use of antimicrobials for patients with resistant bacterial infections. She has published over 50 peer-reviewed papers, and her research program has been supported by federal, foundation, and industry sponsors. Dr. Hirsch has served as an appointed advisor to the Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing since 2017 and is a member of the ongoing IDSA 2019 update of the urinary tract infection guidelines expert panel.
Dr. Hirsch has consistently contributed to SIDP since her membership commenced in 2008. She has served on four separate committees, but dedicated consecutive years to each for continuity and held leadership positions in three including the Policy and Government Affairs (2021-current), Research (2017-2020), and Annual Report (2014-2017) committees. Other contributions to SIDP include the insights Pharmacotherapy paper she led as corresponding author entitled “Antimicrobial susceptibility testing: an updated primer for clinicians in the era of antimicrobial resistance: insights from the Society of Infectious Diseases Pharmacists”, and a clinical microbiology module for the new Antimicrobial Stewardship Certificate Program.